Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	203.24	25.84	8.52
Graham Fair Price	892.42	167718.46	16899.90
PEG	-99.98	< 0.005	-2.70
Price/Book	39.46	2.12	1.52
Price/Cash Flow	-81.59	-4.97	27.00
Prices/Earnings	-98.50	4.08	272.08
Price/Sales	39.39	0.77	0.55
Price/FCF	-81.59	-4.97	27.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-5.15	0.17	0.18
Operating Margin	9304.30	0.07	< 0.005
ROA	9294.47	< 0.005	< 0.005
ROE	< 0.005	0.13	9208.66
ROIC	< 0.005	0.02	9552.70
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.06	0.04	79.84
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.98	95.78	9639.56
EPS QOQ	1.01	94.75	9293.42
FCF QOQ	-0.80	-8.79	-998.64
Revenue QOQ	-0.15	0.03	-81.04
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	79.37	83.22	4.85
Days Sales Outstanding (DSO)	76.35	79.75	4.46
Inventory Turnover	1.13	1.08	-4.63
Debt/Capitalization	0.82	0.83	0.61
Quick Ratio	0.69	0.75	9.05
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	95273.55	704122.15	639.05
Cash	244452.31	211445.34	-13.50
Capex	-11163.66	14387.63	28.88
Free Cash Flow	5369.97	-41835.03	679.06
Revenue	263181.97	270843.34	2.91
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.06	1.06	0.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.39	15.36	184.82
Naive Interpretation	Member

06 - Financial Health · Bad

Rating